This week’s online meeting of the European Union’s members to debate the proposed €750bn Covid-19 recovery plan is vitally important economically and politically.
Having delivered some of the best performances in the stock market so far in 2020, biotechnology shares have encountered a brutal correction over the last few...
Just when stocks looked to be hitting a sticky patch, new stimulus measures by the US Federal Reserve and reports of a potential Trump administration...
Specialist asset manager Polar Capital (POLR:AIM) is a high quality business which produces stable operating margins and high returns on equity which have...
Fighting climate change: the funds and companies with positive solutions. Shares looks at different ways to invest in this space and how returns on many ethical investments have beaten the market.
Discover why global markets have bounced back after a lull and why Shares believes it is time to be more cautious on this year’s biggest biotech winners.
